Supporting Health Centers to Reduce Disparities in Adult Immunization
Welcome to the NACHC-CDC COVID-19 Project Confluence - Project # 877-02
This space will house all Vaccine Hesitancy project-related resources that our partners can use and collaborate with NACHC!
Partner Health Centers
Training Videos (Live & Asynchronous Learning)
TIMELINE/FRAMEWORK
Session Schedule
Please set aside Wednesdays from 12:00- 1:30pm PT from mid-October 2022 to January 2023 for LIVE and ASYNC sessions. · Participating teams are expected to attend LIVE sessions, which take place on Wednesdays from 12:00- 1:30pm PT. · Teams will watch several short video lessons and connect with their coaches on ASYNC weeks. | ||||
|
Week 1 |
Week 2 |
Week 3 |
Week 4 |
OCT | 5th | 12th | Oct 19, 2022 – LIVE – START HERE: Zoom link Agenda: Welcome Back; Phase 2 plan Analogous Examples Recording: | Oct 26, 2022 – ASYNC Agenda: Creating Concepts Solution Directions Recording: |
NOV | Nov 3, 2022 – LIVE: Zoom link Agenda: Solution direction share & feedback Recording: | Nov 9, 2022 – ASYNC Agenda: Prototyping to test Brainstorm what you could try Recording: | Nov 16, 2022 – LIVE- Zoom link Agenda: Crate your prototype (a test idea) Recording: | 23rd – OFF Thanksgiving |
DEC | Nov 30, 2022 – LIVE - Zoom link Agenda: Prototype Test Feedback Test in community Recording: | Dec 7, 2022 – ASYNC Agenda: Office Hours Prototype & Testing advice Recording: | Dec 14, 2022 – LIVE - Zoom link Agenda: Prototype testing share & feedback Recording: | Dec 21, 2022 – ASYNC Agenda: Draft 7-part presentation Recording: |
JAN | 4th – OFF
| Jan 11, 2023 – LIVE -Zoom link Agenda: Get feedback on 7-part presentation Recording: | Jan 18, 2023 – ASYNC Agenda: Feedback on 7-part presentation Finalize 7-part presentation Recording: | Jan 25, 2023 – LIVE - Zoom link Agenda: Final presentation Recording: |
Dear Confluence Users, If you need support for use of Atlassian tools, please contact informatics@nachc.com whether you have technical issues, need feature assistance, or simply have questions.